The Variations in the Immunologic Features and Interleukin-6 Levels for the Surgical Treatment of Cardiac Myxomas

Surgery Today ◽  
2007 ◽  
Vol 37 (9) ◽  
pp. 750-753 ◽  
Author(s):  
Hiroki Yokomuro ◽  
Katsunori Yoshihara ◽  
Yoshinori Watanabe ◽  
Noritsugu Shiono ◽  
Nobuya Koyama ◽  
...  
2015 ◽  
Vol 7 (2) ◽  
pp. 152-155 ◽  
Author(s):  
Nnadozie Ezerioha ◽  
Wuwei Feng

Cerebral aneurysms are well known to be associated with cardiac myxomas. The mechanism of cerebral aneurysm formation remains to be elucidated. Embolization of tumor particles in the vessel wall has been proposed as the likely mechanism for aneurysm formation. Recent reports suggest interleukin-6 (IL-6) may play a role as well. We describe a patient who presented with subarachnoid hemorrhage secondary to ruptured right middle cerebral artery (MCA) aneurysm and unruptured left MCA aneurysm. Subsequently, the patient was found to have an atrial myxoma and persistently elevated serum IL-6 levels. Transcranial Doppler monitoring showed multiple emboli in the right MCA vascular territory on day 1 after surgery but no recurrent embolization during the next 2 weeks on repeated tests. Elevated IL-6 levels were noted both on day 1 and on day 30. Our findings provide evidence that IL-6 elevation and not tumor embolization is likely the culprit for aneurysm formation in some patients with atrial myxoma.


2007 ◽  
Vol 135 (7-8) ◽  
pp. 401-406
Author(s):  
Aleksandar Mikic ◽  
Biljana Obrenovic-Kircanski ◽  
Mladen Kocica ◽  
Mile Vranes ◽  
Vesna Lackovic ◽  
...  

Introduction Cardiac myxomas are the most frequent primary tumors of the heart in adults, and they can be found in each of four cardiac chambers. Although biologically benign, due to their unfavorable localization, myxomas are considered "functionally malignant" tumors. Diagnosis of cardiac myxoma necessitates surgical treatment. Objective To analyze: 1) the influence of localization, size and consistency of cardiac myxomas on preoperative symptomatology; 2) the influence of different surgical techniques (left, right, biatrial approach, tumor basis solving) on early, and late outcomes. Method From 1982 to 2000, at the Institute for Cardiovascular Diseases, Clinical Center of Serbia, there were 46 patients with cardiac myxomas operated on, 67.4% of them women, mean age 47.1?16.3 years. The diagnosis was made according to clinical presentation, electrocardiographic and echocardiographic examinations and cardiac catheterization. Follow-up period was 4-18 (mean 7.8) years. Results In 41 (89.1%) patients, myxoma was localized in the left, while in 5 (10.9%), it was found in the right atrium. Average size was 5.8?3.8 cm (range: 1?1 cm to 9?8 cm) and 6?4 cm (range: 3?2 cm to 9?5 cm) for the left and right atrial myxomas, respectively. A racemous form predominated in the left (82.6%) and globous in the right (80%) atrium. Fatigue was the most common general (84.8%) and dyspnoea the most common cardiologic symptom (73.9%). Preoperative embolic events were present in 8 patients (4 pulmonary, 4 systemic). In our series: 1) different localization, size and consistency had no influence on the preoperative symptomatology; 2) surgical treatment applied, regardless of different approaches and basis solving, resulted in excellent functional improvements (63.1% patients in NYHA III and IV class preoperatively vs. 6.7% patients postoperatively) and had no influence on new postoperative rhythm disturbances (8.7% patients preoperatively vs. 24.4% patients postoperatively); 3) early (97.8%), and late survival rates (91.3%) were excellent; 4) there were no relapses during the follow-up period. Conclusion Localization, size and consistency had no influence on the preoperative symptomatology. Excellent survival rate with significant functional improvement, rare postoperative complications and no recurrences, justify the applied strategies of surgical approach and tumor basis solving in our series.


1996 ◽  
Vol 16 (8) ◽  
pp. 589-593 ◽  
Author(s):  
J.T. PARISSIS ◽  
D. MENTZIKOF ◽  
M. GEORGOPOULOU ◽  
M. GIKOPOULOS ◽  
A. KANAPITSAS ◽  
...  

1997 ◽  
Vol 58 (5) ◽  
pp. 960-963
Author(s):  
Seiji KINUGASA ◽  
Shinjiro SASAKI ◽  
Hiroshi IRIE ◽  
Nanritsu MATSUYAMA ◽  
Junko OKAMOTO ◽  
...  

2020 ◽  
Vol 92 (5) ◽  
pp. 85-91
Author(s):  
T. V. Маrtynuk ◽  
A. M. Aleevskaya ◽  
V. V. Gramovich ◽  
N. M. Danilov ◽  
I. Z. Korobkova ◽  
...  

Takayasu arteritis (TA) is a systemic vasculitis with predominatly lesions of aorta and its large branches. In some cases pulmonary arteries (PA) are involved in the pathological inflammatory process and lead to the formation of pulmonary hypertension and significantly worse the prognosis. Timely development of lesion of PA, appointment of adequate therapy and surgical treatment can prevent irreversible damage of blood vessels and improve the prognosis. Perioperative administration of interleukin-6 inhibitor inhibitor (tocilizumab) in at patients with indications for vascular surgery, including angioplasty PA, should be considered as a promising approach to control the inflammatory activity of TA, reduce the dose of glucocorticoids and the risk of postoperative complications. We present the clinical experience of significant improvement in the patients condition was achieved by using two-stage balloon angioplasty on the background of control of the disease activity with interleukin-6 tocilizumab intravenously and specific therapy with riociguat and iloprost.


1990 ◽  
Vol 50 (4) ◽  
pp. 557-561 ◽  
Author(s):  
Frank W. Sellke ◽  
John H. Lemmer ◽  
Byron F. Vandenberg ◽  
Johann L. Ehrenhaft

1990 ◽  
Vol 33 (3) ◽  
pp. 398-402 ◽  
Author(s):  
Michel Jourdan ◽  
Régis Bataille ◽  
Jacques Seguin ◽  
Xue Guang Zhang ◽  
Paul André Chaptal ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document